• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Telomerase activity is detected in pancreatic cancer but not in benign tumors.

作者信息

Hiyama E, Kodama T, Shinbara K, Iwao T, Itoh M, Hiyama K, Shay J W, Matsuura Y, Yokoyama T

机构信息

Department of General Medicine, Hiroshima University School of Medicine, Minami-ku, Japan.

出版信息

Cancer Res. 1997 Jan 15;57(2):326-31.

PMID:9000577
Abstract

Activation of telomerase and stabilization of telomeres are considered to be necessary for immortalization of human tumor cells. In the present study, telomerase activity was detected in 41 (95%) of 43 pancreatic cancer specimens but was detectable in none of 11 benign pancreatic tumors and only one of 3 pancreatitis samples. Low levels of telomerase activity were detected in 5 (14%) of 36 adjacent "normal" pancreatic tissues. These five telomerase-positive "normal" specimens were obtained from patients that also had pancreatic cancer and may reflect occult microinvasion. Telomerase activity was examined in 12 ex vivo brushing samples of the pancreatic duct, and 8 of 8 with pancreatic cancer had detectable telomerase activity, whereas 0 of 4 of benign lesions (cystadenoma and pancreatitis) did. These findings suggest that telomerase activity in cells derived from pancreatic ducts may be useful in the diagnosis of cancer and that telomerase activity may be a critical or rate-limiting step in pancreatic carcinogenesis.

摘要

相似文献

1
Telomerase activity is detected in pancreatic cancer but not in benign tumors.
Cancer Res. 1997 Jan 15;57(2):326-31.
2
Diagnosis of pancreatic cancer by cytology and telomerase activity in exfoliated cells obtained by pancreatic duct brushing during endoscopy.通过在内镜检查期间对胰管刷检获得的脱落细胞进行细胞学和端粒酶活性检测来诊断胰腺癌。
Hepatobiliary Pancreat Dis Int. 2007 Jun;6(3):308-11.
3
Telomerase activity is a useful marker to distinguish malignant pancreatic cystic tumors from benign neoplasms and pseudocysts.端粒酶活性是区分恶性胰腺囊性肿瘤与良性肿瘤及假性囊肿的有用标志物。
J Surg Res. 1999 Dec;87(2):171-7. doi: 10.1006/jsre.1999.5699.
4
Diagnosis of pancreatic cancer by detecting telomerase activity in pancreatic juice: comparison with K-ras mutations.通过检测胰液中端粒酶活性诊断胰腺癌:与K-ras突变的比较
Am J Gastroenterol. 1999 Sep;94(9):2513-8. doi: 10.1111/j.1572-0241.1999.01386.x.
5
Telomerase elevation in pancreatic ductal carcinoma compared to nonmalignant pathological states.与非恶性病理状态相比,胰腺导管癌中端粒酶水平升高。
Clin Cancer Res. 1997 Jun;3(6):993-8.
6
Telomerase activity in pancreatic juice differentiates ductal carcinoma from adenoma and pancreatitis.胰液中的端粒酶活性可将导管癌与腺瘤及胰腺炎区分开来。
Clin Cancer Res. 1997 Dec;3(12 Pt 1):2479-83.
7
Detection of human telomerase reverse transcriptase (hTERT) expression in tissue and pancreatic juice from pancreatic cancer.胰腺癌组织及胰液中人类端粒酶逆转录酶(hTERT)表达的检测
Surgery. 2008 Jan;143(1):113-25. doi: 10.1016/j.surg.2007.07.042.
8
In situ telomerase activity in pancreatic juice may discriminate pancreatic cancer from other pancreatic diseases.胰液中的原位端粒酶活性可用于鉴别胰腺癌与其他胰腺疾病。
Pancreas. 2008 Apr;36(3):236-40. doi: 10.1097/MPA.0b013e31815bc1d6.
9
Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues.
Cancer Res. 1996 Dec 15;56(24):5600-4.
10
Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.端粒酶与端粒长度在癌前病变发展为结直肠癌过程中的作用
Clin Cancer Res. 1997 Nov;3(11):1931-41.

引用本文的文献

1
Cancer Vaccination and Immune-Based Approaches in Pancreatic Cancer.胰腺癌的癌症疫苗接种及基于免疫的治疗方法
Cancers (Basel). 2025 Jul 15;17(14):2356. doi: 10.3390/cancers17142356.
2
Telomere Length and Telomerase Activity as Potential Biomarkers for Gastrointestinal Cancer.端粒长度和端粒酶活性作为胃肠道癌的潜在生物标志物
Cancers (Basel). 2024 Oct 1;16(19):3370. doi: 10.3390/cancers16193370.
3
Developing Vaccines in Pancreatic Adenocarcinoma: Trials and Tribulations.开发胰腺腺癌疫苗:试验与磨难。
Curr Oncol. 2024 Aug 23;31(9):4855-4884. doi: 10.3390/curroncol31090361.
4
Understanding, diagnosing, and treating pancreatic cancer from the perspective of telomeres and telomerase.从端粒和端粒酶的角度理解、诊断和治疗胰腺癌。
Cancer Gene Ther. 2024 Sep;31(9):1292-1305. doi: 10.1038/s41417-024-00768-6. Epub 2024 Apr 9.
5
Regulation of telomerase towards tumor therapy.端粒酶对肿瘤治疗的调控。
Cell Biosci. 2023 Dec 18;13(1):228. doi: 10.1186/s13578-023-01181-6.
6
Advances in Immunotherapeutics in Pancreatic Ductal Adenocarcinoma.胰腺导管腺癌免疫治疗的进展
Cancers (Basel). 2023 Aug 25;15(17):4265. doi: 10.3390/cancers15174265.
7
Senescence program and its reprogramming in pancreatic premalignancy.衰老程序及其在胰腺前恶性肿瘤中的重编程。
Cell Death Dis. 2023 Aug 17;14(8):528. doi: 10.1038/s41419-023-06040-3.
8
Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer.阻断硝化应激可为胰腺癌中的肿瘤特异性细胞毒性 T 淋巴细胞提供燃料。
J Immunother Cancer. 2022 Jan;10(1). doi: 10.1136/jitc-2021-003549.
9
Role of Telomeres Shortening in Atherogenesis: An Overview.端粒缩短在动脉粥样硬化形成中的作用:概述。
Cells. 2021 Feb 15;10(2):395. doi: 10.3390/cells10020395.
10
Genomic footprints of activated telomere maintenance mechanisms in cancer.癌症中端粒激活维持机制的基因组足迹。
Nat Commun. 2020 Feb 5;11(1):733. doi: 10.1038/s41467-019-13824-9.